Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

New fusion protein from Bristol-Myers Squibb demonstrates antidiabetic activity

July 16, 2012

Lilly presents promising results for the gemcitabine prodrug LY-2334737

July 13, 2012

Clinical data updated for ibrutinib

July 13, 2012

Overall response rate over 80% seen in elotuzumab trial

July 13, 2012

Amgen presents clinical results for ganitumab

July 13, 2012

HM-781-36B proves safe and well tolerated in patients with cancer

July 13, 2012

F-14512 evaluated in phase I acute myeloid leukemia trial

July 13, 2012

Scientists in Taiwan discover new candidate marker of HCC prognosis

July 12, 2012

Human growth hormone analogue displays extended half-life in vivo

July 12, 2012

KinDex Therapeutics describes novel agent for diabetes

July 12, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 1, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
CINP 2026: Gut microbiota could predict antidepressant response
BioWorld
The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...